<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC11077244</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC11077244.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">11077244</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">11077244</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">38715429</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1002/brb3.3533</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">BRB33533</article-id></all-ids><extracted-table><table-id>brb33533-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>Various clinical features of Alzheimer's patients with and without Type 2 diabetes mellitus (T2DM).</table-caption><table-wrap-foot>Note: Normally distributed continuous variables were presented as mean (SD), nonnormally distributed continuous variables were presented as median (Q1–Q3), Categorical variables were presented as counts (percentages).Abbreviations: AD, Alzheimer's disease; eGFR, estimated glomerular filtration rate; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="brb33533-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Various clinical features of Alzheimer's patients with and without Type 2 diabetes mellitus (T2DM).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" rowspan="1" colspan="1">DM and AD (<italic toggle="yes">n</italic>: 31)</th><th align="left" rowspan="1" colspan="1">AD (<italic toggle="yes">n</italic>: 33)</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="char" rowspan="1" colspan="1">74.35 (7.55)</td><td align="char" rowspan="1" colspan="1">75.64 (6.47)</td><td align="char" rowspan="1" colspan="1">.468</td></tr><tr><td align="left" rowspan="1" colspan="1">Female, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">19 (61.3)</td><td align="char" rowspan="1" colspan="1">18 (54.5)</td><td align="char" rowspan="1" colspan="1">.585</td></tr><tr><td align="left" rowspan="1" colspan="1">MMSE</td><td align="char" rowspan="1" colspan="1">17.23 (5.27)</td><td align="char" rowspan="1" colspan="1">18.13 (5.55)</td><td align="char" rowspan="1" colspan="1">.562</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting glucose (mg/dL)</td><td align="char" rowspan="1" colspan="1">130 (102–194)</td><td align="char" rowspan="1" colspan="1">98 (85.25–106)</td><td align="char" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin A1c (%)</td><td align="char" rowspan="1" colspan="1">6.71 (6.10–7.92)</td><td align="char" rowspan="1" colspan="1">5.55 (5.33–5.69)</td><td align="char" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL (mg/dL)</td><td align="char" rowspan="1" colspan="1">120.20 (94.92–171.97)</td><td align="char" rowspan="1" colspan="1">119 (104.42–153.67)</td><td align="char" rowspan="1" colspan="1">.918</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL (mg/dL)</td><td align="char" rowspan="1" colspan="1">50.15 (11.89)</td><td align="char" rowspan="1" colspan="1">56.71 (17.54)</td><td align="char" rowspan="1" colspan="1">.236</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="char" rowspan="1" colspan="1">145 (109–194)</td><td align="char" rowspan="1" colspan="1">85 (68–134)</td><td align="char" rowspan="1" colspan="1">.012</td></tr><tr><td align="left" rowspan="1" colspan="1">TSH (mIU/L)</td><td align="char" rowspan="1" colspan="1">1.06 (0.62–1.37)</td><td align="char" rowspan="1" colspan="1">1.07 (0.76–1.80)</td><td align="char" rowspan="1" colspan="1">.580</td></tr><tr><td align="left" rowspan="1" colspan="1">Ferritin (µg/L)</td><td align="char" rowspan="1" colspan="1">49.84 (40.41–76.54)</td><td align="char" rowspan="1" colspan="1">84.81 (38.89–152.95)</td><td align="char" rowspan="1" colspan="1">.206</td></tr><tr><td align="left" rowspan="1" colspan="1">Iron (µg/dL)</td><td align="char" rowspan="1" colspan="1">50 (38–74)</td><td align="char" rowspan="1" colspan="1">69 (53–104)</td><td align="char" rowspan="1" colspan="1">.096</td></tr><tr><td align="left" rowspan="1" colspan="1">B12 (ng/L)</td><td align="char" rowspan="1" colspan="1">342.5 (231.75–472.50)</td><td align="char" rowspan="1" colspan="1">321 (219–447)</td><td align="char" rowspan="1" colspan="1">.917</td></tr><tr><td align="left" rowspan="1" colspan="1">Folic acid (µg/L)</td><td align="char" rowspan="1" colspan="1">5.95 (3.97–7.52)</td><td align="char" rowspan="1" colspan="1">5.55 (4.22–7.45)</td><td align="char" rowspan="1" colspan="1">.924</td></tr><tr><td align="left" rowspan="1" colspan="1">25(OH)D (ng/mL)</td><td align="char" rowspan="1" colspan="1">19.35 (10.92)</td><td align="char" rowspan="1" colspan="1">21.37 (9.80)</td><td align="char" rowspan="1" colspan="1">.537</td></tr><tr><td align="left" rowspan="1" colspan="1">AST (U/L)</td><td align="char" rowspan="1" colspan="1">17.14 (4.56)</td><td align="char" rowspan="1" colspan="1">19.27 (6.21)</td><td align="char" rowspan="1" colspan="1">.201</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT (U/L)</td><td align="char" rowspan="1" colspan="1">12 (10–22.5)</td><td align="char" rowspan="1" colspan="1">13 (11–19.50)</td><td align="char" rowspan="1" colspan="1">.755</td></tr><tr><td align="left" rowspan="1" colspan="1">Na (mEq/L)</td><td align="char" rowspan="1" colspan="1">139 (135.5–140)</td><td align="char" rowspan="1" colspan="1">141 (139–142)</td><td align="char" rowspan="1" colspan="1">.001</td></tr><tr><td align="left" rowspan="1" colspan="1">K (mmol/L)</td><td align="char" rowspan="1" colspan="1">4.48 (0.52)</td><td align="char" rowspan="1" colspan="1">4.44 (0.51)</td><td align="char" rowspan="1" colspan="1">.654</td></tr><tr><td align="left" rowspan="1" colspan="1">Ca (mg/dL)</td><td align="char" rowspan="1" colspan="1">9.38 (0.41)</td><td align="char" rowspan="1" colspan="1">9.34 (0.55)</td><td align="char" rowspan="1" colspan="1">.795</td></tr><tr><td align="left" rowspan="1" colspan="1">eGFR (mL/min/1.73 m<sup>2</sup>)</td><td align="char" rowspan="1" colspan="1">56.80 (19.73)</td><td align="char" rowspan="1" colspan="1">73.50 (14.79)</td><td align="char" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Urea (mg/dL)</td><td align="char" rowspan="1" colspan="1">43 (33.25–64.25)</td><td align="char" rowspan="1" colspan="1">34 (26.5–41.5)</td><td align="char" rowspan="1" colspan="1">.028</td></tr><tr><td align="left" rowspan="1" colspan="1">BUN</td><td align="char" rowspan="1" colspan="1">19.86 (14.83–31.07)</td><td align="char" rowspan="1" colspan="1">16.35 (12.26–21.26)</td><td align="char" rowspan="1" colspan="1">.077</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatine (mg/dL)</td><td align="char" rowspan="1" colspan="1">1.13 (0.83–1.29)</td><td align="char" rowspan="1" colspan="1">0.88 (0.73–0.96)</td><td align="char" rowspan="1" colspan="1">.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophil (10×3/µL)</td><td align="char" rowspan="1" colspan="1">4.75 (1.34)</td><td align="char" rowspan="1" colspan="1">4.72 (2.09)</td><td align="char" rowspan="1" colspan="1">.948</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocyte (10×3/µL)</td><td align="char" rowspan="1" colspan="1">2.08 (0.54)</td><td align="char" rowspan="1" colspan="1">1.93 (0.59)</td><td align="char" rowspan="1" colspan="1">.294</td></tr><tr><td align="left" rowspan="1" colspan="1">Eosinophils (absolute number)</td><td align="char" rowspan="1" colspan="1">0.21 (0.15–0.39)</td><td align="char" rowspan="1" colspan="1">0.10 (0.07–0.15)</td><td align="char" rowspan="1" colspan="1">.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Monocyte (absolute number)</td><td align="char" rowspan="1" colspan="1">0.55 (0.49–0.69)</td><td align="char" rowspan="1" colspan="1">0.51 (0.45–0.64)</td><td align="char" rowspan="1" colspan="1">.167</td></tr><tr><td align="left" rowspan="1" colspan="1">Basophil (absolute number)</td><td align="char" rowspan="1" colspan="1">0.08 (0.05–0.10)</td><td align="char" rowspan="1" colspan="1">0.06 (0.04–0.08)</td><td align="char" rowspan="1" colspan="1">.081</td></tr><tr><td align="left" rowspan="1" colspan="1">Leukocyte</td><td align="char" rowspan="1" colspan="1">7.74 (1.48)</td><td align="char" rowspan="1" colspan="1">7.47 (2.32)</td><td align="char" rowspan="1" colspan="1">.596</td></tr><tr><td align="left" rowspan="1" colspan="1">Erythrocyte</td><td align="char" rowspan="1" colspan="1">4.34 (0.59)</td><td align="char" rowspan="1" colspan="1">4.57 (0.57)</td><td align="char" rowspan="1" colspan="1">.119</td></tr><tr><td align="left" rowspan="1" colspan="1">Hematocrit</td><td align="char" rowspan="1" colspan="1">38.99 (34.20–40.89)</td><td align="char" rowspan="1" colspan="1">42.29 (38.8–43.93)</td><td align="char" rowspan="1" colspan="1">.001</td></tr><tr><td align="left" rowspan="1" colspan="1">MCH</td><td align="char" rowspan="1" colspan="1">28.7 (26.73–30.30)</td><td align="char" rowspan="1" colspan="1">29.87 (28.22–31.38)</td><td align="char" rowspan="1" colspan="1">.026</td></tr><tr><td align="left" rowspan="1" colspan="1">NLR</td><td align="char" rowspan="1" colspan="1">2.21 (1.94–2.97)</td><td align="char" rowspan="1" colspan="1">2.08 (1.57–3.26)</td><td align="char" rowspan="1" colspan="1">.665</td></tr><tr><td align="left" rowspan="1" colspan="1">PLR</td><td align="char" rowspan="1" colspan="1">112.26 (89.74–150.76)</td><td align="char" rowspan="1" colspan="1">113.71 (87.57–135.35)</td><td align="char" rowspan="1" colspan="1">.851</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin (g/dL)</td><td align="char" rowspan="1" colspan="1">12.15 (1.72)</td><td align="char" rowspan="1" colspan="1">13.53 (1.50)</td><td align="char" rowspan="1" colspan="1">.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet (10×3/µL)</td><td align="char" rowspan="1" colspan="1">221 (182.8–288)</td><td align="char" rowspan="1" colspan="1">198.5 (179.25–264)</td><td align="char" rowspan="1" colspan="1">.166</td></tr><tr><td align="left" rowspan="1" colspan="1">MCV</td><td align="char" rowspan="1" colspan="1">86.20 (7.24)</td><td align="char" rowspan="1" colspan="1">90.24 (7.00)</td><td align="char" rowspan="1" colspan="1">.031</td></tr></tbody></table><table-wrap-foot><fn id="brb33533-tbl1-note-0001"><p><italic toggle="yes">Note</italic>: Normally distributed continuous variables were presented as mean (SD), nonnormally distributed continuous variables were presented as median (Q1–Q3), Categorical variables were presented as counts (percentages).</p></fn><fn id="brb33533-tbl1-note-0002"><p>Abbreviations: AD, Alzheimer's disease; eGFR, estimated glomerular filtration rate; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Various clinical features of Alzheimer's patients with and without Type 2 diabetes mellitus (T2DM).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="char" char="("/><col align="char" char="("/><col align="char" char="."/><thead><tr style="border-bottom:solid 1px #000000"><th align="left">Variable</th><th align="left">DM and AD (n: 31)</th><th align="left">AD (n: 33)</th><th align="left">p</th></tr></thead><tbody><tr><td align="left">Age</td><td align="char">74.35 (7.55)</td><td align="char">75.64 (6.47)</td><td align="char">.468</td></tr><tr><td align="left">Female, n (%)</td><td align="char">19 (61.3)</td><td align="char">18 (54.5)</td><td align="char">.585</td></tr><tr><td align="left">MMSE</td><td align="char">17.23 (5.27)</td><td align="char">18.13 (5.55)</td><td align="char">.562</td></tr><tr><td align="left">Fasting glucose (mg/dL)</td><td align="char">130 (102–194)</td><td align="char">98 (85.25–106)</td><td align="char">&lt;.001</td></tr><tr><td align="left">Hemoglobin A1c (%)</td><td align="char">6.71 (6.10–7.92)</td><td align="char">5.55 (5.33–5.69)</td><td align="char">&lt;.001</td></tr><tr><td align="left">LDL (mg/dL)</td><td align="char">120.20 (94.92–171.97)</td><td align="char">119 (104.42–153.67)</td><td align="char">.918</td></tr><tr><td align="left">HDL (mg/dL)</td><td align="char">50.15 (11.89)</td><td align="char">56.71 (17.54)</td><td align="char">.236</td></tr><tr><td align="left">Triglycerides (mg/dL)</td><td align="char">145 (109–194)</td><td align="char">85 (68–134)</td><td align="char">.012</td></tr><tr><td align="left">TSH (mIU/L)</td><td align="char">1.06 (0.62–1.37)</td><td align="char">1.07 (0.76–1.80)</td><td align="char">.580</td></tr><tr><td align="left">Ferritin (µg/L)</td><td align="char">49.84 (40.41–76.54)</td><td align="char">84.81 (38.89–152.95)</td><td align="char">.206</td></tr><tr><td align="left">Iron (µg/dL)</td><td align="char">50 (38–74)</td><td align="char">69 (53–104)</td><td align="char">.096</td></tr><tr><td align="left">B12 (ng/L)</td><td align="char">342.5 (231.75–472.50)</td><td align="char">321 (219–447)</td><td align="char">.917</td></tr><tr><td align="left">Folic acid (µg/L)</td><td align="char">5.95 (3.97–7.52)</td><td align="char">5.55 (4.22–7.45)</td><td align="char">.924</td></tr><tr><td align="left">25(OH)D (ng/mL)</td><td align="char">19.35 (10.92)</td><td align="char">21.37 (9.80)</td><td align="char">.537</td></tr><tr><td align="left">AST (U/L)</td><td align="char">17.14 (4.56)</td><td align="char">19.27 (6.21)</td><td align="char">.201</td></tr><tr><td align="left">ALT (U/L)</td><td align="char">12 (10–22.5)</td><td align="char">13 (11–19.50)</td><td align="char">.755</td></tr><tr><td align="left">Na (mEq/L)</td><td align="char">139 (135.5–140)</td><td align="char">141 (139–142)</td><td align="char">.001</td></tr><tr><td align="left">K (mmol/L)</td><td align="char">4.48 (0.52)</td><td align="char">4.44 (0.51)</td><td align="char">.654</td></tr><tr><td align="left">Ca (mg/dL)</td><td align="char">9.38 (0.41)</td><td align="char">9.34 (0.55)</td><td align="char">.795</td></tr><tr><td align="left">eGFR (mL/min/1.73 m2)</td><td align="char">56.80 (19.73)</td><td align="char">73.50 (14.79)</td><td align="char">&lt;.001</td></tr><tr><td align="left">Urea (mg/dL)</td><td align="char">43 (33.25–64.25)</td><td align="char">34 (26.5–41.5)</td><td align="char">.028</td></tr><tr><td align="left">BUN</td><td align="char">19.86 (14.83–31.07)</td><td align="char">16.35 (12.26–21.26)</td><td align="char">.077</td></tr><tr><td align="left">Creatine (mg/dL)</td><td align="char">1.13 (0.83–1.29)</td><td align="char">0.88 (0.73–0.96)</td><td align="char">.007</td></tr><tr><td align="left">Neutrophil (10×3/µL)</td><td align="char">4.75 (1.34)</td><td align="char">4.72 (2.09)</td><td align="char">.948</td></tr><tr><td align="left">Lymphocyte (10×3/µL)</td><td align="char">2.08 (0.54)</td><td align="char">1.93 (0.59)</td><td align="char">.294</td></tr><tr><td align="left">Eosinophils (absolute number)</td><td align="char">0.21 (0.15–0.39)</td><td align="char">0.10 (0.07–0.15)</td><td align="char">.001</td></tr><tr><td align="left">Monocyte (absolute number)</td><td align="char">0.55 (0.49–0.69)</td><td align="char">0.51 (0.45–0.64)</td><td align="char">.167</td></tr><tr><td align="left">Basophil (absolute number)</td><td align="char">0.08 (0.05–0.10)</td><td align="char">0.06 (0.04–0.08)</td><td align="char">.081</td></tr><tr><td align="left">Leukocyte</td><td align="char">7.74 (1.48)</td><td align="char">7.47 (2.32)</td><td align="char">.596</td></tr><tr><td align="left">Erythrocyte</td><td align="char">4.34 (0.59)</td><td align="char">4.57 (0.57)</td><td align="char">.119</td></tr><tr><td align="left">Hematocrit</td><td align="char">38.99 (34.20–40.89)</td><td align="char">42.29 (38.8–43.93)</td><td align="char">.001</td></tr><tr><td align="left">MCH</td><td align="char">28.7 (26.73–30.30)</td><td align="char">29.87 (28.22–31.38)</td><td align="char">.026</td></tr><tr><td align="left">NLR</td><td align="char">2.21 (1.94–2.97)</td><td align="char">2.08 (1.57–3.26)</td><td align="char">.665</td></tr><tr><td align="left">PLR</td><td align="char">112.26 (89.74–150.76)</td><td align="char">113.71 (87.57–135.35)</td><td align="char">.851</td></tr><tr><td align="left">Hemoglobin (g/dL)</td><td align="char">12.15 (1.72)</td><td align="char">13.53 (1.50)</td><td align="char">.002</td></tr><tr><td align="left">Platelet (10×3/µL)</td><td align="char">221 (182.8–288)</td><td align="char">198.5 (179.25–264)</td><td align="char">.166</td></tr><tr><td align="left">MCV</td><td align="char">86.20 (7.24)</td><td align="char">90.24 (7.00)</td><td align="char">.031</td></tr></tbody></table></div>Note: Normally distributed continuous variables were presented as mean (SD), nonnormally distributed continuous variables were presented as median (Q1–Q3), Categorical variables were presented as counts (percentages).Abbreviations: AD, Alzheimer's disease; eGFR, estimated glomerular filtration rate; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio.John Wiley &amp; Sons, Ltd.</transformed-table></extracted-table><extracted-table><table-id>brb33533-tbl-0002</table-id><table-label>TABLE 2</table-label><table-caption>Linear regression analysis of variables associated with changes in extractions in the left superior longitudinal fasciculus.</table-caption><table-wrap-foot>Note: Adjusted R square: Model 1 = .122, Model 2 = .100, Model 3 = .069.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="brb33533-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Linear regression analysis of variables associated with changes in extractions in the left superior longitudinal fasciculus.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><thead><tr><th colspan="2" style="border-bottom:solid 1px #000000" rowspan="2" align="left">Model</th><th align="left" rowspan="1" colspan="1">Unstandardized coefficients</th><th align="left" rowspan="1" colspan="1">Standardized coefficients</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic></th><th align="left" rowspan="1" colspan="1">Sig.</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">B</th><th align="left" rowspan="1" colspan="1">Beta</th><th align="char" rowspan="1" colspan="1"/><th align="char" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td rowspan="5" align="left" colspan="1">1</td><td align="left" rowspan="1" colspan="1">(Constant)</td><td align="left" rowspan="1" colspan="1">592,528.151</td><td align="left" rowspan="1" colspan="1">–</td><td align="char" rowspan="1" colspan="1">3.252</td><td align="char" rowspan="1" colspan="1">.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">−3673.498</td><td align="left" rowspan="1" colspan="1">−.251</td><td align="char" rowspan="1" colspan="1">−1.860</td><td align="char" rowspan="1" colspan="1">.069</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c</td><td align="left" rowspan="1" colspan="1">−10,115.553</td><td align="left" rowspan="1" colspan="1">−.196</td><td align="char" rowspan="1" colspan="1">−1.492</td><td align="char" rowspan="1" colspan="1">.142</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT</td><td align="left" rowspan="1" colspan="1">−3486.418</td><td align="left" rowspan="1" colspan="1">−.269</td><td align="char" rowspan="1" colspan="1">−1.966</td><td align="char" rowspan="1" colspan="1">.055</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine</td><td align="left" rowspan="1" colspan="1">−99,415.628</td><td align="left" rowspan="1" colspan="1">−.341</td><td align="char" rowspan="1" colspan="1">−2.460</td><td align="char" rowspan="1" colspan="1">.018</td></tr><tr><td rowspan="4" align="left" colspan="1">2</td><td align="left" rowspan="1" colspan="1">(Constant)</td><td align="left" rowspan="1" colspan="1">496,825.561</td><td align="left" rowspan="1" colspan="1">–</td><td align="char" rowspan="1" colspan="1">2.877</td><td align="char" rowspan="1" colspan="1">.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">−3261.192</td><td align="left" rowspan="1" colspan="1">−.223</td><td align="char" rowspan="1" colspan="1">−1.647</td><td align="char" rowspan="1" colspan="1">.106</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT</td><td align="left" rowspan="1" colspan="1">−3577.193</td><td align="left" rowspan="1" colspan="1">−.276</td><td align="char" rowspan="1" colspan="1">−1.993</td><td align="char" rowspan="1" colspan="1">.052</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine</td><td align="left" rowspan="1" colspan="1">−99,583.093</td><td align="left" rowspan="1" colspan="1">−.342</td><td align="char" rowspan="1" colspan="1">−2.434</td><td align="char" rowspan="1" colspan="1">.019</td></tr><tr><td rowspan="3" align="left" colspan="1">3</td><td align="left" rowspan="1" colspan="1">(Constant)</td><td align="left" rowspan="1" colspan="1">228,353.872</td><td align="left" rowspan="1" colspan="1">–</td><td align="char" rowspan="1" colspan="1">3.933</td><td align="char" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT</td><td align="left" rowspan="1" colspan="1">−3161.588</td><td align="left" rowspan="1" colspan="1">−.244</td><td align="char" rowspan="1" colspan="1">−1.750</td><td align="char" rowspan="1" colspan="1">.086</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine</td><td align="left" rowspan="1" colspan="1">−84,695.928</td><td align="left" rowspan="1" colspan="1">−.291</td><td align="char" rowspan="1" colspan="1">−2.087</td><td align="char" rowspan="1" colspan="1">.042</td></tr></tbody></table><table-wrap-foot><fn id="brb33533-tbl2-note-0001"><p><italic toggle="yes">Note</italic>: Adjusted <italic toggle="yes">R</italic> square: Model 1 = .122, Model 2 = .100, Model 3 = .069.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Linear regression analysis of variables associated with changes in extractions in the left superior longitudinal fasciculus.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/><thead><tr><th colspan="2" style="border-bottom:solid 1px #000000" rowspan="2" align="left">Model</th><th align="left">Unstandardized coefficients</th><th align="left">Standardized coefficients</th><th align="left">t</th><th align="left">Sig.</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left">B</th><th align="left">Beta</th><th align="char"/><th align="char"/></tr></thead><tbody><tr><td rowspan="5" align="left">1</td><td align="left">(Constant)</td><td align="left">592,528.151</td><td align="left">–</td><td align="char">3.252</td><td align="char">.002</td></tr><tr><td align="left">Age</td><td align="left">−3673.498</td><td align="left">−.251</td><td align="char">−1.860</td><td align="char">.069</td></tr><tr><td align="left">HbA1c</td><td align="left">−10,115.553</td><td align="left">−.196</td><td align="char">−1.492</td><td align="char">.142</td></tr><tr><td align="left">ALT</td><td align="left">−3486.418</td><td align="left">−.269</td><td align="char">−1.966</td><td align="char">.055</td></tr><tr><td align="left">Creatinine</td><td align="left">−99,415.628</td><td align="left">−.341</td><td align="char">−2.460</td><td align="char">.018</td></tr><tr><td rowspan="4" align="left">2</td><td align="left">(Constant)</td><td align="left">496,825.561</td><td align="left">–</td><td align="char">2.877</td><td align="char">.006</td></tr><tr><td align="left">Age</td><td align="left">−3261.192</td><td align="left">−.223</td><td align="char">−1.647</td><td align="char">.106</td></tr><tr><td align="left">ALT</td><td align="left">−3577.193</td><td align="left">−.276</td><td align="char">−1.993</td><td align="char">.052</td></tr><tr><td align="left">Creatinine</td><td align="left">−99,583.093</td><td align="left">−.342</td><td align="char">−2.434</td><td align="char">.019</td></tr><tr><td rowspan="3" align="left">3</td><td align="left">(Constant)</td><td align="left">228,353.872</td><td align="left">–</td><td align="char">3.933</td><td align="char">&lt;.001</td></tr><tr><td align="left">ALT</td><td align="left">−3161.588</td><td align="left">−.244</td><td align="char">−1.750</td><td align="char">.086</td></tr><tr><td align="left">Creatinine</td><td align="left">−84,695.928</td><td align="left">−.291</td><td align="char">−2.087</td><td align="char">.042</td></tr></tbody></table></div>Note: Adjusted R square: Model 1 = .122, Model 2 = .100, Model 3 = .069.John Wiley &amp; Sons, Ltd.</transformed-table></extracted-table></extracted-tables-set>